We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

52 hedge funds and large institutions have $5.62M invested in AEON Biopharma Inc in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $5.67M → $5.62M (-$51.3K)

2% less funds holding

Funds holding: 53 → 52 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
6
Closed
8
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
+$19K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$10.8K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$4.67K
3
HIM
HGC Investment Management
Ontario, Canada
+$3.37K
4
CIM
Cowen Investment Management
New York
+$1.01K
5
CS
Clear Street
New York
+$636

Top Sellers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$11.5K
2
UOC
UBS O'Connor
Illinois
-$8K
3
Verition Fund Management
Verition Fund Management
Connecticut
-$7K
4
MF
Magnetar Financial
Illinois
-$5K
5
AGM
Alpine Global Management
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.9M – – –
LP
2
LMR Partners
United Kingdom
$2.01M – – –
AC
3
Athos Capital
Hong Kong
$299K – – –
SCM
4
Segantii Capital Management
Hong Kong
$167K – – –
Parallax Volatility Advisers
5
Parallax Volatility Advisers
California
$39.9K -$11.5K -283,977 -24%
CF
6
Cantor Fitzgerald
New York
$27K – – –
SCM
7
Shaolin Capital Management
Florida
$20K – – –
PC
8
Periscope Capital
Ontario, Canada
$19.8K – – –
AC
9
Aristeia Capital
Connecticut
$12.5K – – –
CAC
10
Cowen and Company
New York
$12.2K +$10.8K +267,522 New
DKCM
11
Davidson Kempner Capital Management
New York
$11K – – –
TCM
12
Tenor Capital Management
New York
$7.6K – – –
KC
13
Kepos Capital
New York
$7K – – –
QGA
14
Q Global Advisors
Texas
$6K – – –
BNP Paribas Financial Markets
15
BNP Paribas Financial Markets
France
$5.28K +$4.67K +115,714 New
CH
16
CVI Holdings
Delaware
$4.91K -$1.34K -33,144 -24%
Hudson Bay Capital Management
17
Hudson Bay Capital Management
Connecticut
$4.56K – – –
Wells Fargo
18
Wells Fargo
California
$4.32K – – –
WA
19
Whitebox Advisors
Minnesota
$4.2K – – –
KL
20
KIM LLC
Kansas
$4K – – –
HIM
21
HGC Investment Management
Ontario, Canada
$4K +$3.37K +83,333 New
Calamos Advisors
22
Calamos Advisors
Illinois
$3.8K – – –
Goldman Sachs
23
Goldman Sachs
New York
$3.63K – – –
CCA
24
Castle Creek Arbitrage
Colorado
$3.19K – – –
Balyasny Asset Management
25
Balyasny Asset Management
Illinois
$3.04K – – –
1
2 3

AEON.WS Hedge Fund Activity: Q4 2022 in Review

52 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q4 2022, worth a combined $5.62M — down 0.9% from $5.67M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AEON.WS and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.

The largest buyer was Cowen and Company, opening a new position worth an estimated $10.8K. The largest seller was Parallax Volatility Advisers, cutting an estimated $11.5K.

  • 52 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $5.62M of AEON Biopharma Inc stock for Q4 2022, down 0.9% quarter-over-quarter.
  • 7 funds opened new AEON Biopharma Inc positions in Q4 2022 and 8 closed out, a net change of -1 holder.
  • The largest AEON Biopharma Inc buyer in Q4 2022 was Cowen and Company, an estimated $10.8K added.
  • The largest AEON Biopharma Inc seller in Q4 2022 was Parallax Volatility Advisers, an estimated $11.5K sold.

Based on aggregated 13F filings for Q4 2022.